albuterol HFA (Armstrong's) + albuterol HFA (Proventil HFA) + HFA placebo

Phase 3Terminated
0 watching 0 views this week๐Ÿ“ˆ Rising
72
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Sep 1, 2007 โ†’ Aug 1, 2008

About albuterol HFA (Armstrong's) + albuterol HFA (Proventil HFA) + HFA placebo

albuterol HFA (Armstrong's) + albuterol HFA (Proventil HFA) + HFA placebo is a phase 3 stage product being developed by Amphastar Pharmaceuticals for Asthma. The current trial status is terminated. This product is registered under clinical trial identifier NCT00635505. Target conditions include Asthma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00635505Phase 3Terminated